HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.
Mo Tang, Speaker at Cancer Conferences
Chongqing Cancer Hospital, China

Abstract:

Background: Little is known about the relationship between psychosomatic symptoms and different occupations in patients with advanced cancer. Aim: To assess the prevalence of psychosomatic symptoms and the status of symptom burden management among advanced cancer survivors with different occupations in China.

Material and methods: A secondary analysis based on a multicenter cross-sectional study in China. The MD Anderson Symptom Inventory and the Hospital Anxiety and Depression Scale were used via electronic patient-reported outcome platform. Symptom management associated with reported "moderate to severe" (MS) symptoms in different occupations were identified. The data were analysed with descriptive statistics and inter-group comparisons.

Results: A total of 1763 advanced cancer patients were included. Almost 50% of patients reported at least one MS symptom. The prevalence of anxiety and depression symptoms was approximately 25%–34%. The rate of receiving symptom management was 28.1% in blue-collar workers, 36.5% in white-collar workers and 20.0% in self-employed participants. Statistically significant differences were observed among the three groups.

Conclusions and significance: Patients with advanced cancer experience relatively high levels of psychosomatic burden, and white-collar workers may receive better symptom management. There are unaddressed comorbidities associated with cancer in China and inadequate symptom management remains an urgent public healthcare problem

Biography:

Dr. Mo Tang has 12 published papers as the first author, including 6 indexed in the Science Citation Index (SCI). She is currently serving as a physician in the Department of Integrated Traditional Chinese and Western Medicine at Chongqing Cancer Hospital (February 2025–present). Prior to this, she completed a postdoctoral fellowship in Psychosocial Oncology at Peking University Cancer Hospital & Institute in September 2024. Dr. Tang earned her doctoral degree in Colorectal Cancer with a focus on integrated Chinese and Western medicine from the China Academy of Chinese Medical Sciences in Beijing (2019–2022). She also holds a master’s degree in Lung Cancer (Integrated Chinese and Western Medicine) from Chongqing Medical University (2016–2019), where she previously completed her bachelor's degree in the same field (2011–2016).

Watsapp
a